Richard Grant to Anti-HIV Agents
This is a "connection" page, showing publications Richard Grant has written about Anti-HIV Agents.
Connection Strength
0.144
-
Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States. AIDS Behav. 2018 Nov; 22(11):3540-3549.
Score: 0.144